Elixir Clinical Research Co., Ltd. logo — Technology-based Full Function CRO

Elixir Clinical Research Co., Ltd.

Technology-based Full Function CRO

Founded 2019 China China 70 employees Series A Total: $52.00M Biotechnology, Pharmaceutical

General Information

Company Name Elixir Clinical Research Co., Ltd.
Founded Year 2019
Location China China
Employees 70
Industries Biotechnology, Pharmaceutical
Funding Stage Series A
Social

BounceWatch is an independent company data service, not affiliated with Elixir Clinical Research Co., Ltd.. To contact Elixir Clinical Research Co., Ltd., visit elixir-research.com.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

About Elixir Clinical Research Co., Ltd.

Elixir Clinical Research Co., Ltd. is a technology-based full service CRO based in China. Founded in 2019, Elixir Clinical Research is a benchmark project empowered by Taimei Technology, aimed at supporting innovation and development within the CRO industry. They are committed to accelerating the accessibility of innovative drugs and have provided qualified and effective clinical research solutions to hundreds of pharmaceutical companies, enabling the swift launch of new drugs in the market. The company recently secured a significant $52.00M Series A investment on 26 April 2022 from prominent investors such as Sinovation Ventures, LYFE Capital, and Chow Tai Fook. As a player in the biotechnology and pharmaceutical industries, Elixir Clinical Research is well-positioned to continue its growth trajectory and make a lasting impact in the healthcare and pharmaceutical sectors.

Taxonomy: CRO, Clinical Research, Clinical Monitoring, QA, Clinical Development, RWE, Medical Affairs, Regulatory Affairs, BE Study

Funding Rounds & Investors (1)

View All
Funding Stage Amount Investors Lead Investors Date
Series A $52.00M 3
Sinovation Ventures, LYFE Capital +1
26 Apr 2022

Elixir Clinical Research Co., Ltd. Alternatives & Competitors

View All Alternatives
Elixir Clinical Research Co., Ltd. vs
CR Clinical
CR Clinical United States

CR Clinical, LLC is a full service provider specializing in providing custom services in the clinica...

3 employees
Biotechnology, Health Care
Elixir Clinical Research Co., Ltd. vs

Raptim Research Pvt. Ltd. is a quality-oriented full-service contract (clinical) research organizati...

526 employees
Biotechnology, Health Care
Elixir Clinical Research Co., Ltd. vs
Catawba Research
Catawba Research United States

Providing state-of-the-art clinical trial & data management services to the pharmaceutical and biote...

Venture round
67 employees
Biotechnology, Pharmaceutical

FAQ About Elixir Clinical Research Co., Ltd.

Technology-based Full Function CRO
Elixir Clinical Research Co., Ltd. was founded in 2019.
Elixir Clinical Research Co., Ltd. is headquartered in China.
Elixir Clinical Research Co., Ltd. operates in Biotechnology and Pharmaceutical. Its work centres on CRO, Clinical Research, Clinical Monitoring and QA.
Elixir Clinical Research Co., Ltd. has approximately 70 employees.
Elixir Clinical Research Co., Ltd. has completed 1 funding round, raising a total of $52.00M. The latest funding stage is Series A.
Top alternatives and competitors to Elixir Clinical Research Co., Ltd. include CR Clinical, Raptim Research Pvt. Ltd., Catawba Research, PharPoint Research, Inc., 4Clinics. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Elixir Clinical Research Co., Ltd. and CR Clinical are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for Elixir Clinical Research Co., Ltd., https://bouncewatch.com/company/elixir-clinical-research-co-ltd, updated 15 January 2025. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Book a demo 30 minutes